Rapid target validation in a Cas9-inducible hiPSC derived kidney model.
Ontology highlight
ABSTRACT: Recent advances in induced pluripotent stem cells (iPSCs), genome editing technologies and 3D organoid model systems highlight opportunities to develop new in vitro human disease models to serve drug discovery programs. An ideal disease model would accurately recapitulate the relevant disease phenotype and provide a scalable platform for drug and genetic screening studies. Kidney organoids offer a high cellular complexity that may provide greater insights than conventional single-cell type cell culture models. However, genetic manipulation of the kidney organoids requires prior generation of genetically modified clonal lines, which is a time and labor consuming procedure. Here, we present a methodology for direct differentiation of the CRISPR-targeted cell pools, using a doxycycline-induci
SUBMITTER: Shamshirgaran Y
PROVIDER: S-EPMC8368200 | biostudies-literature | 2021 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA